Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Dermatology
Inflammatory Bowel Disease
Questions discussed in this category
How would you approach the treatment of an SLE patient with refractory mucocutaneous ulcerations and lichenoid skin eruption despite treatment with MMF, Aza, Benlysta, Saphnelo, Rituximab, and JAK inhibitors?
The patient was diagnosed on the basis of ANA 1:1,280, strongly positive Smith, Sm-RNP, dsDNA, pericarditis, inflammatory arthritis, and discoid lupus...
3 Answers available
Do you have concerns with the use of oral contraceptives in patients on JAK inhibitors given the black box warning for thromboembolic events?
How has this impacted your counseling and management?
2 Answers available
Do you have a preference between Quantiferon Gold and T-spot TB for screening in patients starting immunosuppressive agents?
1 Answer available
How do you counsel patients who ask if there are any dietary modifications they can make to help control their autoimmune disease?
This question is part of a collaboration with RheumMadness and is specifically in reference to: ADIRA Diet
1 Answer available
22244
16189
17574
7826
Related Topics in Dermatology
Lung Cancer
Breast Cancer
Head and Neck Cancers
Hematologic Malignancies
Radiation Oncology
Gynecologic Cancers
Palliation
Gastrointestinal Cancers
Genitourinary Cancers
Melanoma/Skin Cancer